Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127971991 | 12797199 | 1 | I | 200507 | 20100621 | 20160929 | 20160929 | EXP | US-ASTRAZENECA-2010BM07354 | ASTRAZENECA | 748.00 | MON | F | Y | 117.90000 | KG | 20160930 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127971991 | 12797199 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | A543193A | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||||
| 127971991 | 12797199 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | A686604A | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||||
| 127971991 | 12797199 | 3 | C | ACTOS /SCH/ | 2 | Oral | 0 | 30 | MG | QD | |||||||||
| 127971991 | 12797199 | 4 | C | DILTIAZEM. | DILTIAZEM | 1 | Oral | 0 | 180 | MG | QD | ||||||||
| 127971991 | 12797199 | 5 | C | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 0 | 1 | DF | QD | ||||||||
| 127971991 | 12797199 | 6 | C | VITAMINS | VITAMINS | 1 | 0 | ||||||||||||
| 127971991 | 12797199 | 7 | C | METHYLSULFONYLMETHANE | DIMETHYL SULFONE | 1 | Unknown | 0 | |||||||||||
| 127971991 | 12797199 | 8 | C | GLUCOSAMINE COMPLEX | GLUCOSAMINEGLUCOSAMINE SULFATE | 1 | Unknown | 0 | |||||||||||
| 127971991 | 12797199 | 9 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127971991 | 12797199 | 1 | Type 2 diabetes mellitus |
| 127971991 | 12797199 | 2 | Type 2 diabetes mellitus |
| 127971991 | 12797199 | 3 | Type 2 diabetes mellitus |
| 127971991 | 12797199 | 4 | Hypertension |
| 127971991 | 12797199 | 5 | Hypertension |
| 127971991 | 12797199 | 7 | Arthralgia |
| 127971991 | 12797199 | 8 | Arthralgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127971991 | 12797199 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127971991 | 12797199 | Arthralgia | |
| 127971991 | 12797199 | Arthritis infective | |
| 127971991 | 12797199 | Asthenia | |
| 127971991 | 12797199 | Blood glucose increased | |
| 127971991 | 12797199 | Body height decreased | |
| 127971991 | 12797199 | Decreased appetite | |
| 127971991 | 12797199 | Expired product administered | |
| 127971991 | 12797199 | Fall | |
| 127971991 | 12797199 | Fear of injection | |
| 127971991 | 12797199 | Gait disturbance | |
| 127971991 | 12797199 | Injection site bruising | |
| 127971991 | 12797199 | Injection site haemorrhage | |
| 127971991 | 12797199 | Joint injury | |
| 127971991 | 12797199 | Joint swelling | |
| 127971991 | 12797199 | Muscle strain | |
| 127971991 | 12797199 | Pain in extremity | |
| 127971991 | 12797199 | Peripheral swelling | |
| 127971991 | 12797199 | Sensory loss | |
| 127971991 | 12797199 | Tremor | |
| 127971991 | 12797199 | Walking aid user |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127971991 | 12797199 | 1 | 200507 | 20100620 | 0 | |
| 127971991 | 12797199 | 2 | 20100620 | 0 |